Works matching IS 10781552 AND DT 2013 AND VI 19 AND IP 4
Results: 18
Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A retrospective study of patients’ out-of-pocket costs for granulocyte colony-stimulating factors.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Reviewers List.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 384, doi. 10.1177/1078155213509756
- Publication type:
- Article
Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 338, doi. 10.1177/1078155213499387
- By:
- Publication type:
- Article
Syndrome of Inappropriate Antidiuretic Hormone after vinorelbine treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 380, doi. 10.1177/1078155212473003
- By:
- Publication type:
- Article
Methotrexate nephrotoxicity: Novel treatment, new approach.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 373, doi. 10.1177/1078155212473002
- By:
- Publication type:
- Article
A retrospective study of patients’ out-of-pocket costs for granulocyte colony-stimulating factors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 328, doi. 10.1177/1078155212473001
- By:
- Publication type:
- Article
Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 348, doi. 10.1177/1078155212470388
- By:
- Publication type:
- Article
Romiplostim resistance in secondary failure of platelet recovery.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 369, doi. 10.1177/1078155212469640
- By:
- Publication type:
- Article
Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 377, doi. 10.1177/1078155212468923
- By:
- Publication type:
- Article
Development of a closed drug preparation method for oral anticancer drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 315, doi. 10.1177/1078155212467554
- By:
- Publication type:
- Article
Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 365, doi. 10.1177/1078155212466421
- By:
- Publication type:
- Article
Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 305, doi. 10.1177/1078155212466123
- By:
- Publication type:
- Article
Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 321, doi. 10.1177/1078155212469243
- By:
- Publication type:
- Article
Evaluation of sources to document extended shelf lives of compounded cytostatics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 355, doi. 10.1177/1078155212465996
- By:
- Publication type:
- Article
Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 291, doi. 10.1177/1078155212465215
- By:
- Publication type:
- Article
Adverse drug events resulting in admission to the intensive care unit in oncology patients: Incidence, characteristics and associated cost.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 298, doi. 10.1177/1078155212465995
- By:
- Publication type:
- Article